Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the Manchester children's growth and vascular health study

J Clin Endocrinol Metab. 2011 Aug;96(8):2567-74. doi: 10.1210/jc.2011-0046. Epub 2011 Jun 1.

Abstract

Context: Adiponectin, high-density lipoprotein cholesterol (HDL-C) and insulin concentrations may be important in the pathophysiology of cardiovascular disease.

Objective: We tested the hypothesis that serum adiponectin rather than insulin differs from early life, between South Asians and Europeans, with a potentially key role in excess cardiovascular risk characteristic of adult South Asians.

Design and participants: We conducted a longitudinal study of 215 British-born children of European (n = 138) and South Asian (n = 77) origin, from birth to 3 yr.

Main outcome measure: Serum adiponectin, insulin, proinsulin and HDL-C concentrations were assessed in relation to ethnic group and growth in anthropometric variables from 0-3 yr of age.

Results: Serum adiponectin was lower in South Asian children, despite their smaller size, notable at age 3-6 months (9.5 vs. 11.8 mg/liter; P = 0.04), with no ethnic differences in serum lipids or insulin or proinsulin. In mixed-effects longitudinal models for HDL-C, determinants were adiponectin (P = 0.034), age (P < 0.001), and body mass index (P < 0.001) but not ethnicity. None of these or growth variables affected either insulin or proinsulin. In a fully adjusted mixed-effects longitudinal model including age, sex, insulin, and proinsulin, the independent determinants of serum adiponectin were height [21.3 (95% confidence interval = 31.7-10.8 cm lower, for every 1 mmol/liter increase in adiponectin, P < 0.001], HDL-C [2.8 (1.3-4.2) mmol/liter higher, P < 0.0001], body mass index (lower, P = 0.03), and South Asian ethnicity (lower, P = 0.01).

Conclusions: These British South Asian-origin infants have lower serum adiponectin but no differences in HDL-C or insulin molecules. In South Asians, factors affecting adiponectin metabolism in early life, rather than insulin resistance, likely determine later excess cardiovascular risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Asia / ethnology
  • Asian People / statistics & numerical data*
  • Cardiovascular Diseases / ethnology*
  • Cardiovascular Diseases / metabolism
  • Child Development / physiology*
  • Child, Preschool
  • Cholesterol, HDL / blood*
  • England / epidemiology
  • Female
  • Humans
  • Infant
  • Infant Welfare / statistics & numerical data
  • Infant, Newborn
  • Insulin / blood
  • Male
  • Risk Factors
  • Triglycerides / blood
  • White People / statistics & numerical data*

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Cholesterol, HDL
  • Insulin
  • Triglycerides